Eagle Pharmaceuticals, Inc. (EGRX) SEC filings
EGRX SEC filings moved a median of -0.83% by the close. EGRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the EGRX overview →
39 measured EGRX SEC filing events.
Where these EGRX SEC filings landedvs 39 measured EGRX SEC filing reactions
| Middle 50% of EGRX SEC filing reactions | -3.77% to +7.44% |
|---|---|
| Median reaction (to close) | -0.83% |
| Measured reactions | 39 |
Point-in-time · zero look-ahead
Half of the 39 EGRX SEC filing events with a measured close landed between -3.77% and +7.44%; 44% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G EAGLE PHARMACEUTICALS, | SEC filing · Form 15-12G | +76.44% | +76.44% | |
| Form EFFECT EAGLE PHARMACEUTICALS, | SEC filing · Form EFFECT | +0.00% | +0.00% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Dec 02 | SEC filing · Form 8-K | +0.00% | +2.67% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Nov 21 | SEC filing · Form 8-K | +0.00% | +183.55% | |
| Form POS AM EAGLE PHARMACEUTICALS, | SEC filing · Form POS | +0.00% | -2.74% | |
| Form RW EAGLE PHARMACEUTICALS, | SEC filing · Form RW | +0.00% | -2.74% | |
| Form S-8 POS EAGLE PHARMACEUTICALS, | SEC filing · Form S-8 | +0.00% | -2.74% | |
| Form 25 EAGLE PHARMACEUTICALS, | SEC filing · Form 25 | +0.00% | +183.55% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Nov 15 | SEC filing · Form 8-K | +0.00% | +30.21% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | +0.00% | -16.67% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Nov 08 | SEC filing · Form 8-K | +0.00% | +12.51% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Oct 30 | SEC filing · Form 8-K | +0.00% | +20.00% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Sep 27 | SEC filing · Form 8-K | -12.23% | -23.02% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Aug 21 | SEC filing · Form 8-K | +0.86% | +11.83% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | +0.00% | -1.22% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Aug 01 | SEC filing · Form 8-K | +5.46% | +3.56% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Jul 03 | SEC filing · Form 8-K | +0.49% | -1.31% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: May 28 | SEC filing · Form 8-K | -2.58% | -13.47% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: May 20 | SEC filing · Form 8-K | +0.00% | -11.39% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: May 14 | SEC filing · Form 8-K | +2.46% | -1.60% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | +0.00% | -0.88% | |
| Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K | Press release | -1.71% | +18.18% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Apr 08 | SEC filing · Form 8-K | -1.71% | +18.18% | |
| Form NT 10-K EAGLE PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | +1.09% | -5.55% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Mar 08 | SEC filing · Form 8-K | +2.31% | -3.13% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Feb 29 | SEC filing · Form 8-K | +0.51% | +10.02% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Feb 28 | SEC filing · Form 8-K | -1.12% | -6.39% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Feb 08 | SEC filing · Form 8-K | +0.83% | -4.40% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Jan 18 | SEC filing · Form 8-K | -5.23% | +2.96% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Jan 12 | SEC filing · Form 8-K | -3.65% | -2.74% | |
| Form 8-K/A EAGLE PHARMACEUTICALS, For: Nov 27 | SEC filing · Form 8-K | +0.40% | +4.81% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Dec 12 | SEC filing · Form 8-K | +3.24% | +2.81% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Dec 06 | SEC filing · Form 8-K | -0.17% | +2.04% | |
| Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q | Press release | -14.74% | -18.27% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Nov 27 | SEC filing · Form 8-K | -14.74% | -18.27% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Nov 09 | SEC filing · Form 8-K | -2.96% | -27.67% | |
| Form NT 10-Q EAGLE PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | +2.26% | -0.11% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Oct 24 | SEC filing · Form 8-K | -0.07% | +4.87% | |
| Form 8-K EAGLE PHARMACEUTICALS, For: Oct 23 | SEC filing · Form 8-K | +0.83% | -0.83% |
Keep exploring
More EGRX: earnings → · analyst actions → · EGRX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | 558 | -0.32% | 41% |
| PERNIX THERAPEUTICS HOLDINGS (PTX) | 557 | -0.19% | 41% |
| Titan Medical Inc. - Ordinary Shares (TMDI) | 552 | -0.06% | 43% |
| Exelixis, Inc. (EXEL) | 548 | -0.02% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.